Curriculum Vitae
---------------------------------PERSONAL INFORMATION:
Surname: Naseripour
First name: Masood
Title: MD
WORK ADDRESS:
Rassoul Akram Hospital, Niayesh Street,
Sattar-khan Street.
Tehran, Iran
Phone: +982166509162
Academic degree: Professor
The University / Department:
Ophthalmology Department / Iran University of Medical Sciences / Tehran / Iran
Phone number: +98-21-66509162
Fax: + 98-21-66509162
E-mail: masoodnp@yahoo.com
1
Education:
1983–1989
School of Medicine/ Tabriz University of Medical Sciences, Doctor of Medicine
Tabriz, Iran
1989–1992 School of Medicine/ Tabriz University of Medical Sciences,
Ophthalmology, Tabriz, Iran
1993–1995
School of Medicine/ Iran University of Medical Sciences, Vitreoretinal
surgery, Tehran, Iran
2000–2001
Wills Eye Hospital, ocular oncology, Philadelphia, USA
Work Experience:
Ophthalmologist / Member of Faculty/ Ophthalmology Department / Kermanshah
University of Medical Sciences / 1995 – 2000
Head of Ophthalmology Department / Kermanshah University of Medical Sciences / 1996
– 1997
Deputy for Education and Research/ Kermanshah University of Medical Sciences / 1997 –
2000
Secretary of Iranian Council for Graduate Medical Education 2001-2004
Ophthalmologist / Member of Faculty /Ophthalmology Department / Iran University of
Medical Sciences / 2001 – up to now
Head of Ophthalmology Department / Iran University of Medical Sciences / 2005 – 2007
Member of Board of Trustee/ Kermanshah University of Medical Sciences / 2004 – 2008
Head of IUMS Eye Research Center 2003-2010
2
SCIENTIFIC POSITIONS
1. Professor, Director of Ocular Oncology unit, Eye Department, Rassoul Akram Hospital, Iran
University of Medical Sciences, Tehran, Iran.
2. Scientific Member, Iranian Retina Society, Tehran, Iran, since 2001.
3. Scientific Reviewer for the journal of “ BINA”, Iranian Eye Bank journal, Iran, since 2002.
4. Scientific Reviewer for the journal of “ Ir J Ophthalmology”, journal of the Iranian Society Of
Ophthalmology, Iran, since 2002.
5. Scientific Reviewer for the journal of “ Behbood”, Kermanshah University of medical sciences ,
since 1998.
6. Editorial Board for the journal of “ Ir J Ophthalmology”, journal of the Iranian Society Of
Ophthalmology, Iran, since 2005.
7. Editorial Board for the journal of “ Behbood”, Kermanshah University of medical sciences ,
since 1998.
8. Editorial Board for the journal of “ Medical Education”, Shahid Beheshti University of medical
sciences , since 2003
9. Scientific Reviewer for the journal of “ Saudi Journal of Ophthalmology”, Saudi Arabia since
2010
10. Scientific Reviewer for the journal of “Middle East African Journal of Ophthalmology”,
Middle East African Council of Ophthalmology2012
3
Publications:
1) Naseripour M, Parvaresh MM. Predisposing factors of Retinal Detachment and Prophylactic
Treatment. Iranian Ophthalmology journal of bina 1996; 1( 4): 47-64
2) Naseripour M, Parvaresh MM. Prophylactic Laser Treatment in Patients with Symptomatic
Retinal Breaks. Bina J Ophthalmol 1999; 4(2):128-133
3) Naseripour M, Parvaresh MM. Scleral buckling Result and Related Risk factors. Iranian
Ophthalmology journal of bina 1999; vol 4(4): 335-340
4) Naseripour M, Iranfar S. Evaluation of Educational Activities of the Faculty of Kermanshah
University of Medical Sciences from medical student’s Standpoint. Iranian journal of Behbood
2000; vol 4( 3): 27-32
5) Naseripour M, Shields CL, Shields J, Guyer DR. Pseudohypopyon of Orange Pigment
Overlying a Stable Choroidal Nevus. Am j Ophthalmol 2001; 132: 416-417.
6) Shields CL, Naseripour M, Shields J. Topical
Mitomycin C for Extensive Recurrent
Conjunctival-Corneal Squamous Cell Carcinoma. Am j Ophthalmol 2002; 133: 601-606.
7) Mirzazadeh A, Tavakoli S, Naseripoor M. Comparison of Graduate Medical Education in Iran
with WFME International Guidelines: Quality Improvement in Postgraduate Medical Education.
Iranian Journal of Medical Education. No. 8, 2002. 37-38.
8) Shields J, Shields CL, Naseripour M, Eagle RC, Miller J. Choroidal Melanoma in a Black
Patient with Oculodermal Melanocytosis. Retina 2002; 22: 126-128
4
9) Shields CL, Naseripour M, Shields J, Eagle RC. Topical Mitomycin C for Pagetoid Invasion
of the Conjunctiva by Eyelid Sebaceous Gland Carcinoma. Ophthalmology 2002; 109: 21292133.
10) Shields CL, Naseripour M, Cater J, Shields J, Demirci H, Youseff A, Freire J. Plaque
Radiotherapy for Large Posterior Uveal Melanomas in 354 Consecutive Patients.
Ophthalmology 2002; 109: 1838-1849.
11) Shields CL, Naseripour M, Shields J, Freire J, Cater J. Custom-Designed Plaque
Radiotherapy for Nonresectable Iris Melanoma in 38 Patients: Tumor Control and Ocular
Complications. Am J Ophtalmol 2003; 135: 648- 656.
12) Panda, A., Bajaj, M.S., Balasubramanya, R., Prakash, G., Shields, C.L., Naseripour, M., Shields,
J.A.
Topical mitomycin C for conjunctival-corneal squamous cell carcinoma [1] (multiple letters)
(2003) American Journal of Ophthalmology, 135 (1), pp. 122-124.
13) Naseripour M, Parvaresh MM, Bakhtiari P, Afsar N. Transpupillary Thermotherapy for
Treatment of Occult Subfoveal Choroidal
Neovascularization in Age Related Macular
Degeneration. Iranian J Ophthalmol 2004; 17(3):49-57.
14) Mirzadeh A, Hashemi H, Naseripour M, Fotouhi A, Yazdani K, Tavakoli S, Raisi B, Taj M.
Establishment of New Evaluation and Accrediation System for Graduate Medical Education in
Iran. Journal of Medical Education summer 2004; 5(2):69-73.
15) Naseripour M, Bakhtiari P, Mogadam AZ, Vosogh P, Naseripour Majid, Salimi S. Combined
chemoreduction and adjuvant therapy to control advanced retinoblastoma. Iranian Journal of
Ophthalmology 2005; 18(4.): 91-98.
5
16) Naseripour M. Retinoblastoma. Iranian Journal of Ophthalmology 2006; 19(1.): 35-48.
17) Naseripour M, Ansari MR, Sheikhi F, Danesghgar F, Omidian J, Ghaderi E.
Retinopathy Prevalence and Its Risk Factors in Diabetics at Kermanshah Diabetes Research
Center (1994-2000). Iranian journal of Behbood 2006; 9(4): 44-51.
18) Naseripour M, Bakhtiari P, Salimi S, Kashkouli MB, Sadeghipour AR. Rubeosis iridis
complicating acquired astrocytoma of solitary optic nerve head; A clinicopathologic case
report. Iranian Journal of Ophthalmology 2006;19:60-64.
19)
Sanjari S, Falavarjani GK, Parvaresh MM, Modarres-zadeh M, Naseripour M, Nojomi
M. Vitreopapillary Traction in Non-arteritic Anterior Ischemic Optic Neuropathy. Bina J
Ophthalmol, 2006; 11(3):289-293.
20)
Sanjari MS, Falavarjani KG, Parvaresh MM, Modarreszadeh M, Naseripour M, Nojomi
M. Vitreopapillary Traction in Nonarteric Anterior Ischemic Optic Neuropathy. Iranian J
Ophthalmic Res 2006; 1(2): 110-112.
21) Naseripour M, falavarjani KG, Akbarzadeh S. Retinocytoma Associated with Bilateral
Retinoblastoma. Bina J Ophthalmol 2007;1 (13):130-132.
22)
Kashkouli MB, Salimi S, Aghaee H, Naseripour M. Bilateral pseudomonas aeruginosa
endophthalmitis following bilateral simultaneous cataract surgery. Indian J Ophthalmol.
2007 sep- oct; 55 (5):374-375.
23) Kashkouli MB, Reaee R, Nilforoushan N, Salimi Sh, Foroutan AR, Naseripour M. Topical
Antiglaucoma Medications and Lacrimal Drainage system obstruction. Ophthal Plast Reconstr
surg 2008; 24 (3):172-5.
6
24) Sadeghipour AR, Abolhasani M, Naseripour M. Association of Vessel Density and Vascular
Endothelial Growth Factor with Local Invasive Growth in Ocular Retinoblastoma,Hazrat
Rasool Akram Hospital 2000-2006. Journal of Iran University of Medical Sciences. 2008; 57
(14): 133-141.
25) Naseripour M, Akbarzadeh S, Ahadian A, Vosough P. The Role of periocular
carboplatin in treatment of advanced intraocular retinoblastoma. Iran J Ophthalmol 2008;
20(1):16-19.
26) Kashkouli MB, Salimi S, Bakhtiari P, Parvaresh MP, Sanjari MS, Naseripour M. EMLA
Cream Application without Occlusive Dressing Before upper facial Botulinum Toxin
Injection. A Randomized Double-Blind Placebo-Controlled Trial. Annals of plastic Surgery
Volume 60, Number 4, April 2008; 353-356.
27) Naseripour M, Nazari H, Bakhtiari P, Modarreszadeh M, Vosough P, Ansari M.R, Ahadian A.
Investigation of Outcomes and Prognosis of Patients with Retinoblastoma after Primary
Chemotherapy and Focal Treatment Based on International (A-E) Classification. Bina J
Ophthalmol 2008; 14(1): 3-9.
28) Moderreszadeh M, Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Paravaresh
MM. Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal
Neovascularization Associated with Age Related Macular Degeneration . J Ophthalmic Vis Res
2008; 3(2): 102-107.
29) Naseripour M, Nikeghbali A, Vadipour A, Bakhtiari P, Ahadian A. Combined Tranpupillary
thermotherapy
with
subtenon
triamcinolone
injection
in
treatment
of
choroidal
neovasculariaztion secondary to exudative age related macular degeneration. Armaghane danesh
J 2008; 13 (1): 1-13.
7
30) Naseripour M, Kashkouli MB, Jaberi MS, Aghaee GH, Ahadian A. Plaque Radiotherapy in
Recurrent or Incomplete-Excised Conjunctival Squamous Cell
Carcinoma and Melanoma.
Iranian J Ophthalmol 2008; 20 (3): 19-23.
31) Naseripour M, Nazari H, Bakhtiari P, Modareszadeh M, Vosough P, Ansari MR, Ahadian A.
Outcomes and prognosis of treatment for retinoblastoma with primary chemotherapy and focal
treatment. Bina J ophthalmology 2008, 14 (1):3-9.
32) Naseripour M, Nazari H, Bakhtiari P, Modarres M, Vosough P, Ausari M. Retinoblastoma in
Iran: outcomes in terms of patients' survival and globe survival. (2009) Br J ophthalmol. Jan; 93
(1):28-32.
33) Naseripour M, Akbarzadeh S, Bakhtiari P, Ahadian A. Adjuvant Effects of Periocular
Chemotherapy in Treatment of Advanced Intraocular Retinoblastoma. Journal of Iran
University of Medical Sciences 2008 . 62(16)187-193
34) Modares-zadeh M. Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Parvaresh
MM. Intravitreal Injection of 2.5 mg VERSUS 1.25 mg Bevacizumab (Avastin) for
Treatment of Choroidal Neovascularization(CNV) Associated with Age-related Macular
Degeneration (AMD). Retina 2009 mar; 29(3): 319-24.
35) Naseripour M, Falavarjani KG, Mirfallah K, Begheri SR. Photodynamic therapy for
vasoproliferative tumors and capillary hemangiomas of retina. Bina J Ophthalmol 2009;
14(2): 109-115.
،‫ محمد علی عقابیان‬،‫ صدیقه مرجانه حجازی‬،‫) هانیه محمد رضا‬36
‫خلیل‬
،‫زرین‬
‫رضا‬
‫محمد‬
،‫پور‬
‫ مسعود ناصری‬،‫علیرضا احمدیان‬
‫ اندازه گیری مساحت عروق تازه‬.‫ حسین نظری‬،‫قاسمی فالورجانی‬
‫تشکیل شده ناشی از بیماری استحاله وابسته به سن ماکوال با‬
8
‫ مجله فیزیک‬.‫استفاده از روش آستانه گذاری اتسو تغییر یافته‬
‫ پاییز و زمستان‬،)20،21( ‫ پیاپی‬،2 ‫ شماره‬5 ‫ دوره‬،‫پزشکی ایران‬
.87
37) Nazari H, Modarreszadeh M, Kashkouli MB, Naseripour M, Parvaresh MM, Nazari P. Central
retinal artery perfusion following 0.1 ml intravitreal injection of Bevacizumab. Iran J
Ophthalmol 2009;21(2):13-18.
38) Naseripour M, Nazari H, Bakhtiari P, Ahadian A, Jaberi R. Ruthenium 106 Plaque for retinal
vasoproliferative tumors. Iran J Ophthalmol 2009;21(2):31-35.
39) Saadat S, Naseripour M, Rahimi B. Safety preparedness of urban community for new year
fireworks in tehran. In press BURNS. Burns 35(2009) 719-722.
40) Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM.
Intravitreal injection of
bevacizumab before vitrectomy for proliferative diabetic
retinopathy. Eur J Ophthalmol 2009; 19: 848-852.
41) Naseripour M, Falavarjani GH, Oladi MR, Modarre M. Testing Toxicity of Intravitreal
Bevacizumab (Avastin) used for the Treatment of Choroidal Neovascularization
Associated with Age-Related Macular Degeneration: A Full Field ERG Study. Iranian
Journal of Ophthalmology 2009;21(3):49-55
42) Falavarjani KG, Nikeghbali A, Modarreszadeh M, Hashemi M, Parvaresh MM,
Naseripour M. Longterm Results of Fixation of Dislocated Intra Ocular Lenses Using
Hoptic Externalization Through a Clear Corneal Incision. No 63 vol 16 Journal of Iran
University of Medical Sciences 2009.
9
43) Naseripour M, Falavarjani KG, Bakhtiari P, Vosough P, Aryad F. Retinoblastoma
survival in iran 10 tears experience of a referral center. Iranian Journal of Ophthalmology
2009;21(4):17-24.
2010
44) Saadat S, Naseripour M, Smith GA. The health and economic impact of fireworks-related
injuries in Iran: a household survey following the New Year's Festival in Tehran. Injury. 2010
Jul;41(7):e28-33.
45) Naseripour M, Falavarjani KG, Akbarzadeh S. Retinocytoma associated with bilateral
retinoblastoma. Indian J Ophthalmol. 2010 Mar-Apr;58(2):155-156.
46) Saadat S, Naseripour M, Karbakhsh M, Rahimi Movaghar V. Perceived risk and risktaking behavior during the festival firework. Am J Health Behav. 2010;34(5): 525-531.
47) Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic macular
edema following panretinal photocoagulation. Arch Ophthalmol. 2010 Feb;128(2):262;
48) Falavarjani KG, Mohammadreza H, Marjaneh Hejazi S, Naseripour M. A Modified
Semiautomatic Method for Measurement of Hyperfluorescence Area in Fluorescein
Angiography. Iranian Journal of Ophthalmology 2010;22(4):73-79 .
49) Saadat S, Naseripour M, Karbakhsh M, Rahimi-Movaghar V. Perceived risk and risktaking behavior during the festival firework. Am J Health Behav. 2010 Sep-Oct;34(5):525531.
50) Falavarjani KG, Naseripour M. New hope for retinoblastoma patients. J Ophthalmic Vis Res.
2010 Jul;5(3):213-4.
10
51) Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic macular
edema following panretinal photocoagulation. Arch Ophthalmol. 2010 Feb;128(2):262;
52) Samiy N, Harandi ZA, Naseripour M, Lai TY. Bilateral elevated macular lesions. J
Ophthalmic Vis Res. 2011 Jan;6(1):55-62.
53) Naseripour M, Retinoblastoma survival disparity’’: The expanding horizon in developing
countries. Saudi J of ophthalmology (2012) 26, 157-161.
54) Kashkouli MB, Heirati A, Pakdel F, Kiavash V, Naseripour M, Aghamohammadi F. Longterm follow-up of invasive ocular surface squamous cell carcinoma treated with excision,
cryotherapy, and topical mitomycin C. (2012) Graefe's Archive for Clinical and Experimental
Ophthalmology, 250 (10), pp. 1527-1532.
55) Naseripour M. Retinoblastoma survival disparity’’: The expanding horizon in developing
countries. Saudi J of ophthalmology (2012) 26, 157-161.
56) Falavarjani KG, Modarres M, Hashemi M, Parvaresh MM, Naseripour M, Zare-Moghaddam
A, Nekoozadeh S. Incidence of Acute Endophthalmitis after Intraviteral Bevacizumab
Injection In a single clinical center. Retina. 2013 Feb 7. [Epub ahead of print]
57)
Saliminejad, K., Behnam, B., Akbari, M.T., Khorshid, H.R.K., Ghassemi, F., Amoli, F.A.,
Akhondi, M.M., Vosoogh, P., Naseripour, M., Ahani, A. Rapid detection of RB1 recurrent
mutations in retinoblastoma by ARMS-PCR. (2013) Journal of Genetics, pp. 1-5. Article in
Press.
58) Falavarjani, K.G., Modarres, M., Hashemi, M., Parvaresh, M.M., Naseripour, M., ZareMoghaddam, A., Nekoozadeh, S. Incidence of acute endophthalmitis after intravitreal
bevacizumab injection in a single clinical center. (2013) Retina, 33 (5), pp. 971-974.
11
59) Ahani, A., Akbari, M.T., Saliminejad, K., Behnam, B., Akhondi, M.M., Vosoogh, P.,
Ghassemi, F., Naseripour, M., Bahoush, G., Khorshid, H.R.K. Screening for large
rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex
ligation-dependent probe amplification. (2013) Molecular Vision, 19, pp. 454-462.
60) Khalil Ghasemi Falavarjani, Masih Hashemi, Mehdi Modarres, Mohammad Mehdi Parvaresh,
Masood Naseripour, Hossein Nazari, Ali Jalili Fazel. Vitrectomy for Posterior Segment
Intraocular Foreign Bodies, Visual and Anatomical Outcomes. Middle East African Journal of
Ophthalmology, Volume 20, Number 3, July - September 2013
12
RESEARCH PROJECTS:
1. Congenital Cataract Incidence in Tabriz 1992
2 Diabetic Retinopathy Cumulative Incidence Rate and Related Risk factors in "Diabetic Research
Center" patients. 1993
3. Efficacy of Argon laser Trabeculoplasty in Primary Open Angle Glaucoma. 1995
4. Epidemiological Study of Diabetic retinopathy and risk factors since Diagnosis in diabetic
patients of Kermanshah Diabetic Research center. 1999
5. Health and Diseases Evaluation in Community Based Medical Education Field in Kermanshah
1999
6. Efficacy of Transpupillary Thermotherapy for Occult Sub-foveal CNV. 2003
7. Efficacy of Sub threshold Grid Laser photocoagulation in Patients with symptomatic 2003
8 The Determination of prevalence of eye related macular degeneration in population after than 40
years old in Kermanshah province in 2005
9. Macular thickness and retinal nerve fiber layer thickness evaluation following brachytherapy of
intra-ocular tumors. 2004
10. Combined chemoneduction and periocular carboplatin in treatment of advanced retinoblastoma.
2004
11. The evaluation of the results of ruthenium 106 plaque radiotherapy for the treatment of
intraocular choroidal malignant melanoma. 2005
12. Comparison of different dose (1.25 and 2.5mg) of intravitreal Bevacizumab (Avastin) with
combined intravitreal Avastin (1.25 mg) and Triamcinolon (2 mg) in exudative age-related macular
degeneration. A double-blind clinical trial. 2005
13. The investigation of outcomes and prognosis of patients with Retinoblastoma following primary
chemoreduction and focal treatment based on International (A-E) classification 2006.
14. Electrophysiologic findings (GERG) after interavitreal Avastin (Bevacizumab) treatment in
choroidal neovascular membrane. 2007
15. The evaluation of the Photodynamic therapy for retinal vascular tumors of retina. 2008
16. Designing and development of a calculating system to measure the hyperfleurecent areas in
retinal angiography. 2008
17. Investigation of Sandwichtherapy for Choroidal Melanoma
13
18. Comparative study of disease–free ratio in the patients with uvula melanoma and monosomy-3
with and without adjuvant therapy (temozolamid and peginterferon α-2b). 2008
19. The evaluation of the results of primary transpupillary thermotherapy in posterior pole small
choroidal melanomas. 2008
20. Detection of Mutations in total exon and promotor of the Rb1 gene in hazrate rasol hospital
retinoblastoma patients by using exon by exon PCR-SSCP analysis. 2008
21. Incidence rate of injuries due to fire work at last Wednesday of solar year in Tehran. 2005
22. Mutation profiling of RB1 gene in patients with retinoblastoma . 2009
23. Photodynamic therapy for retinal vasoproliferative and angiomatous tumors of retina. 2008
24. Frequency of Monosomy-3 in patients with uveal melanoma according to Chromosome in
situ hybridization in patients attending to in Rasoul Akram Hospital from 2003 to 2013 . 2011
25. Preparation and In Vivo Evaluation of Nanoliposomes containing Melphalan after Intravitreal
Administration . 2011
14
Conference Presentations:
1) Deep Vitrectomy Result in Patients with Active PDR.
4th National Ophthalmologic seminar, Tehran, Iran 1994
2) Episcleral Balloon in Patients with Retinal Detachment.
5th Ophthalmology Congress, Tehran, Dec. 1995
3) Retinal Detachment Management by Episcleral Parabulbar Balloon. The First Report from Iran
The First International Ophthalmology Congress, Tehran-Iran, 1995
4) Prognostic Factors in Intraocular Foreign Bodies.
7th Iranian Ophthalmologic Congress, Isfahan, Iran 1997
5) Results of Prophylactic Laser therapy in retinal detachment.
8th Ophthalmologic Congress, Tehran, Iran 1998
6) Scleral buckling Result and Prognostic Factors.
8th Ophthalmologic seminar, Tehran, Iran 1998
7) New in Retinoblastoma.
Second International Ophthalmology Congress, Tehran-Iran, 2001
8) Management of Choroidal Malignant Melanoma.
2nd International Ophthalmology Congress, Tehran, Iran, 2001
9) Health and Diseases Status in Aged People in Community Oriented Medical Education Field in
Kermanshah.
2nd Health and Preventive Medicine Seminar, Kermanshah, Iran, 2001.
15
10) Prevalence of Abnormal Red Reflex in Community Based Medical Education Field in
Kermanshah. Kermanshah, Dec. 2001
11) Retinoblastoma: Early Diagnosis or Presenting Symptoms Education?
23rd Congress of advances in Pediatric, Tehran, May 2002
12) Evaluation of Patients with Intraocular Tumor.
Tehran, Iran, Feb 2002.
13) Analytic Comparison of New Accreditation System for Graduate.
Medical Education in Iran with ACGME and RCPSC Ahwaz, 2002
14) How to Approach to a Patient with Intraocular Tumor.
Shahid Beheshti UMS. Tehran, Feb 2002.
15) Transpupillary Thermotherapy for Treatment of Occult Choroidal Neovascularization.
13th Ophthalmology Congress, Tehran, Dec. 2003.
16) Partial Lamellar Sclerouvectomy for Management of ciliary Body tumors.
13th Ophthalmology Congress, Tehran, Dec. 2003.
17) Transpupillary Thermotherapy for Management of Choroidal Melanoma.
13th Ophthalmology Congress, Tehran, Dec. 2003
18) Partial Lamellar Sclerouvectomy:A Safe Procedure for Saving the Eyes with Ciliary body
Tumor.
XI International Congress of Ocular Oncology Jan 2004, Hyderabad, India
16
19) Are Combined Chemoreduction and Adjuvant treatment Sufficient to Control the Patients with
Advanced Retinoblastoma?
XI International Congress of Ocular Oncology Jan 2004, Hyderabad, India
20) Visual Results Following Transpupillry Thermotherapy of Choroidal Neovascularization In
Patients with Exudative ARMD.
4th EURETINA Congress, Milan, Italy, May 2004.
21) Transpupillary Thermotherapy of Occult and Classic Choroidal Neovascularization in Patients
with Age-Related Macular Degeneration.
Naseripour M, Parvaresh M.M, Bakhtiari P, Afsar N, Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
22) Ruthenium 106 Plaque Radiotherapy in Intraocular Tumors.
Naseripour M, Tarassoli K, Jaberi R, Samiee F, Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
23) Combined Chemoreduction and Adjuvant Therapy to Control Retinoblastoma.
Naseripour M, Bakhtiari P, Zare Moghadam A, Vosough P. Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
24) Optic Disc Astrocytoma Case Report.
Naseripour M, Bakhtiari P, Imani M, Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
25) Medulloepithelioma of Ciliary Body.
Naseripour M, Bakhtiari P, ZareMoghadam A, Dec 2004
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
17
26) Surgical and Anatomic Outcome of Pars Plana Vitrectomy with Silicon Oil Tamponade without
Buckle Placement for the Treatment of Primary Rhegmatogenous Retinal Detachment
Parvaresh MM, Naseripour M, Bakhtiari P.
20th ASIA Pacific Academy of Ophthalmology Congress
27) Prevalence and Risk Factors of Supra-choroidal Hemorrhage in Scleral Surgery
Bakhtiari P, Parvaresh MM, Naseripour M.
20th ASIA Pacific Academy of Ophthalmology Congress
28) Ruthenim 106 plaque radiotherapy in treatment of choroidal tumor.
Naseripour M, Bakhtiari P, Jaberi R, Kheirkhah R, Samiee F.
International VIIIth Congress of the Pan Arab African Council of Ophthalmology (PAACO) and
the XIIth UAE Ophthalmic Conference April2005 Dubai
29) Combined Chemoreduction and Adjuvant Therapy to Control Retinoblastoma.
Naseripour M, Bakhtiari P, Moghadam A, Vosough P, Nasrabadi M
International VIIIth Congress of the Pan Arab African Council of Ophthalmology (PAACO) and
the XIIth UAE Ophthalmic Conference April 2005 Dubai (P)
30) Optic Nerve Astrocytoma
Naseripour M, Bakhtiari P, Imani M,Sadeghipour.
Ophthalmology (PAACO) and the XIIth UAE Ophthalmic Conference April 2005 Dubai (P)
31) Do We Need Effective Modalities to Control the Patients with Advanced Retinoblastoma?
Naseripour M, P. Bakhtiari, SH. Salimi, P Vosough.
ISGED and IRS 2005 & ICOO 2005 Canada
32) Regression of Advanced Retinoblastoma after Multiple Subconjunctival Carboplatin Injection
Naseripour M, N. Bahrivand, A. Vadipour, P. Bakhtiari
18
ISGED and IRS 2005 & ICOO 2005 Canada
33) Plaque Radiotherapy in Vitrectomized Eye with Recurrent Retinoblastoma
Naseripour M, M Hashemi, R Jaberi, M Almasi Nasrabadi
ISGED and IRS 2005 & ICOO 2005 Canada
34) Transpupillary
Thermotherapy
(TTT)
for
Treatment
of
Idiopathic
Choroidal
Neovascularization(o)
Naseripour M, Nikeghbali A, Ariaeetabar H, Bakhtiari P.
15th Iranian Congress of Ophthalmology. 15-18 December 2005 Tehran
35) Brachytherapy Using Ruthenium-106 Plaque for Choroidal Management Methods (O)
Naseripour M, Jaberi R, Bakhtiari P, Kheirkhah A, AliAkbar Navahi R
15th Iranian Congress of Ophthalmology. 15-18 December 2005 Tehran
36) Case-Control Study of Occurrence of Predictors of Anterior Hyaloid Fibro vascular Proliferation
after Diabetic Vitrectomy .
Parvaresh MM, Naseripour M, Bakhtiari P, Khodadoust A
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
37) Intravitreal Triamcinolone Injection for Treatment of Macular Edema Due to BRVO (O)
Hashemi M,Parvaresh MM, Naseripour M, Manshai K
15th Iranian Congress of Ophthalmology. 15-18 December 2005 Tehran
38) Intravitreal Triamcinolone Injection for the Treatment of Macular Edema due to CRVO (O)
Hashemi M, Parvaresh MM, Naseripour M, Manshai K
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
39)Intravitreal Triamcinolone Injection for CSME as Primary Treatment (O)
19
Hashemi M, Parvaresh MM, Naseripour M, Manshai K
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
40) Transpupillary Thermotherapy (TTT) for Treatment of Choroidal Neovascularization due to
Myopia (P)
Naseripour M, Hashemi M, Ariaeetabar H, Bakhtiari P
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
41) Transpupillary Thermotherapy (TTT) for Treatment of
Occult, Classic and Mixed-Type Choroidal Neovascularization (CNV) in Age Related Macular
Degeneration (ARMD) (O)
Naseripour M, Parvaresh MM, Bakhtiari P, Manshai K,Salimi SH
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
42) Transpupillary Thermotherapy (TTT) as primary Treatment or Adjuvant to plaque Radiotherapy
for Choroidal Malignant Melanoma (O).
Naseripour M, Parvaresh MM, Ariaeetabar H, Bakhtiari P
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
43) Do We Need More Effective Modalities to Control the Patients with Advanced Retinoblastoma?
(O) . Naseripour M, Bakhtiari P, ZareMoghadam A, Salimi SH, Vosough P
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
44) Nerve Fiber Layer (NFL) and Macular Thickness Measurment by Optical Coherence
Tomography
(OCT) in Emmetropic, High Myopic and High Hyperopic Eyes
Parvaresh MM, Imani M, Naseripour M, Bakhtiari P, Salimi SH
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
20
45) Ten years Survival Rate Study of Patients with Retinoblastoma in Iran.
Naseripour M, P Vosough, F Arian, P Bakhtiari, SH Salimi
Saudi Ophthalmology Congress March 2006
47) Case- Control Study of Occurrence of Predictors of Anterior Hyaloid Fibrovascular
Proliferation Naseripour M, M Parvaresh, P Bakhtiari, A Khodadoust
Saudi Ophthalmology Congress March 2006
48) Brachytherapy Using Ruthenium -106 Plaque for Choroidal Melanoma
Naseripour M, R Jaberi, P Bakhtiari, A Kheirkhah, S Ali
Saudi Ophthalmology Congress March 2006
49. Optical Coherence Tomography (OCT) in Emmetropic, High-Myopic and High- Hyperopic
Eyes.
Naseripour M, M Parvaresh, P Bakhtiari, M Imani, A Kheirkhah
Saudi Ophthalmology Congress March 2006
50. Plaque Brachytherapy in Uveal Melanoma
Ramin Jaberi, Naseripour M, Farhad Samiei
The 3 th National Scientific Congress of IRSA 2005
51. The role of hyperthermia in control of subfoveal CNV: stabilization of CNV with low recurrent
rate.
Naseripour M, Pejman Bakhtiari,
XVI Ophthalmology Congress of Iran , November 2006
52. Evaluation of periocular carboplatin injection combined with chemotherapy for advanced
intraocular retinoblastoma . Naseripour M, Akbarzadeh S, Bakhtiari P, Vosough P, Vadipour A
XVI Ophthalmology Congress of Iran, November 2006
21
53. Efficacy of the Intravitreal Injection of Bevacizumab (Avastin) For Treatment of Wet – Type
ARMD.
Naseripour M, Ansari MR, Modarreszadeh M, Bakhtiari P, Salimi Sh
XVI Ophthalmology Congress of Iran
November 2006
54. Plaque Radiotherapy for ocular surface tumors.
Naseripour M, Ansari MR, Jaberi R, Bakhtiari P, Salimi Sh.
XVI Ophthalmology Congress of Iran November 2006
55. Ten Years Survival Rate Study of Patients with Retinoblastoma In Iran.
Naseripour M, Vosough P, Arian F, Bakhtiari P, Salimi SH.
XVI Ophthalmology Congress of Iran , November 2006
56. The effect of transpupillary thermotherapy with or without Sub – Tenon triamcinolon injection
for the treatment of CNV due to ARMD.
Naseripour M, Vadipour A, Parvaresh MM, Bakhtiari P, Salimi Sh
XVI Ophthalmology Congress of Iran, November 2006
57. High dose versus low dose ruthenium 106 plaque radiotherapy for retinal vasoproliferative
tumors (VPT).
Naseripour M , Bakhtiari P, Jaberi R
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
58. The prognosis of retinoblastoma in terms of patient’s survival and globe survival
Naseripour M., Bakhtiari P., Ansari M.R., Vosough P.
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
22
59. Retinoblastoma: Predictor factors for patients survival
Naseripour M., Bakhtiari P., Vosough P., Arian F.
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
60. Ruthenium 106 plaque radiotherapy for choroidal malignant melanoma: 5 years experience.
Naseripour M, Nazari H, Bakhtiari P, Jaberi R.
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
61. Visual and anatomical results of brachytherapy in circumscribed choroidal hemangioma.
Naseripour M, Bakhtiari P, Nazari H, Jaberi R
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
62) High Dose versus Low Dose Ruthenium 106 Plaque Radiotherapy for Retinal Vasoproliferative
Tumors.
Naseripour M, Bakhtiari P, Nazari H, Jaberi R
17th Iranian Congress of Ophthalmology, Tehran, 4-7 December 2007.
63) Intravitreal Injection of Bevasizumb before Vitrectomy for Proliferative Diabetic Retinopathy;
Modarreszadeh M, Naseripour M.
17th Iranian Congress of Ophthalmology . Tehran, 4-7 December 2007.
64) Ruthenium 106 Plaque Radiotherapy for Choroidal Malignant Melanoma: 5 Years
Experiences.; Naseripour M, Bakhtiari P, Jaberi R.
17th Iranian Congress of Ophthalmology. Tehran, 4-7 December 2007.
65) Intravitreal Injection of Bevacizumab for Treatment of Macular Edema after Retinal Vein
Occlusion.
Naseripour M, Modarreszadeh M, Ansari MR, Falavarjani KG.
Middle East African council of ophthalmology . UAE, Dubai. April-March 2007.
23
66) Ruthenium-106 Plaque Radiotherapy for Choroidal Malignant Melanoma: 5 Years Experinces;
Naseripour M, Nazari H, Bakhtiari P, Jaberi R.
4th Asian Congress of Safe Communities. Thiland, 21-24 November 2007.
67) Bevacizumab and Retinal Ischemia
Naseripour M, MD.
Annual meeting of Retina society. Iran, Zibakenar, 15 May 2008.
68) Age related macular degeneration
Naseripour M, MD.
11th Annual Optometry Congress, Sep 2007 Tehran, Iran.
68- Current and New pharmacologic treatments of ARMD
Retina and Vitreous Seminar, June 2006 Tehran, Iran.
69- Sarcoidosis presenting as a choroidal tumor.
Auther (s) Nazari H. Naseripour M. (Posters) XVIII Ophthalmology Congress of IRAN. 25-27
Nov 2008.
70- Anti angiogenic therapy with intravitreal bevacizumab for aggressive posterior retinopathy of
prematurity (APROP) unresponsive to conventional laser therapy. Nazari H, Parvaresh MM,
Hashemi M, Modarreszadeh M, Naseripour M, Nikeghbali A. (Free papers) XVIII
Ophthalmology Congress of IRAN. 25-27 Nov 2008.
71- Visual function and predictor factors following brachytherapy for circumscribed choroidal
hemangioma. Naseripour M. (Free papers) XVIII Ophthalmology Congress of IRAN. 25-27
Nov 2008.
24
72- Intravitreal use of bevacizumab (avastin) for choroidal neovascularization associated with age
related macular degeneration; a fuul field ERG study. Naseripour M. (Free papers). XVIII
Ophthalmology Congress of IRAN. 25-27 Nov 2008.
73- Photodynamic therapy in retinal angiomatosis proliferations. Naseripour M. (Free papers).
XVIII Ophthalmology Congress of IRAN. 25-27 Nov 2008.
74- Primary transpupillary thermotherapy for small choridal melanoma. Naseripour M. (Free
papers). XVIII Ophthalmology Congress of IRAN. 25-27 Nov 2008.
75- Ruthenium brachythrapy for retinoblastoma. Naseripour M. (Free papers). XVIII
Ophthalmology Congress of IRAN. 25-27 Nov 2008.
76- When to continue or to discontinue Avastin in exudative ARMD. Naseripour M
6-8 March 2009, Tehran Razi Convention Center.
77- Pharmacotherapy for retinal capillary hemangioma, vasoproliferative tumors and coat` disease.
Naseripour M.
6-8 March 2009, Tehran Razi Convention Center.
78- When to countinue or to descountinue Avastin in exudative ARMD. 6-8 March.
Naseripour M. 2009, Tehran Razi Convention Center.
79- Pharmacotherapy for retinal capillary hemangioma, vasoproliferative tumors and coat` disease.
Naseripour M. 6-8 March 2009, Tehran Razi Convention Center.
25
80-. Ocular tumor management & it`s complication.12th Iranian Congress of Optometry.
Naseripour M .18-20 August 2009. Tehran Razi Convention Center.
81- Uveal melanoma management : Lessons from cytogenetic profiling .
Naseripour M. 3rd annual meeting of Iranian Retina Society. 22 Apr 2010 . Shiraz
82- Update on retinal disease and glaucoma: Panel discussion.
Naseripour M. 16th annual meeting of TUMS Eye Research center 5-7 May 2010, Tehran
83-. The Role of cataract surgery in macular disease.
Naseripour M . 4th annual meeting of IUMS Eye Research center, 21-23 july 2010 Tehran
84-. Approach to a fundus mass.
Naseripour M, ghasenmi F XXAnnual Congress of the Iran society of Ophthalmology 8-11
)1389 ‫)آذرماه‬
85- ‫) مورخه‬1( ‫اتوفلورسانی نرمال فوندوس در بیماری استحاله وابسته به سن شبکیه سمینار یکروزه زجاجیه و شبکیه‬
‫ دکتر مسعود ناصری پور‬89/12/19
86- Retinoblastoma Survival in Iran.
Naseripour M. SIOP Asia 2010, 3-5 March 2010 Kish Island
87- Surgical approach in Retinoblastoma.
Naseripour M. 6th Congress of the SIOP Asia. March 3-5 2010, Iran-Kish Island
88- Ravindranath Y, Naseripour M, Epelman S, Vossough P.
6th Congress of the SIOP Asia. Mrch 3-5 2010, Iran-Kish Island
89- Workshop: Approach to a fundus mass.
26
Naseripour M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2,
2010
90- Differential diagnosis of an amelanotic fundus mass. XX Annual Congress of the Iranian
Society of ophthalmology Nov.29- Dec.2, 2010.
91- Approach to a fundus mass. Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
92- Updates on managements of AMD. Naseripour M. XX Annual Congress of the Iranian
Society of ophthalmology Nov.29- Dec.2, 2010.
93- Salvage Ru-106 Plaque Radiotherapy after failed primary chemotherapy for advanced
Retinoblastoma . Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
94-Trends in survival of Retinoblastoma patients in an ocular oncology unit in iran : 1991-2010.
Naseripour M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2,
2010.
95-Controversies in vitreoretinal surgical techniques. (To Peal LIM? / Pros / Cons). Naseripour
M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2, 2010.
96- Approach to a fundus mass. Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
97- Approach to a fundus mass. Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
27
‫ می شود ؟‬ARMD , DME ‫ جراحی کاتاراکت باعث تشدید بیماریهای ماکوال‬-98
‫دکتر ناصری پور – دکتر کارخانه – دکتر هاشمی – دکتر رمضانی‬
Controversies in ophthalmology 21-23 july 2010
99- EYELID.
Demerci H, Naseripour M.
Biannual Meeting ISOO 2011, 14-17 November.
100- Mystery case.
Naseripour M.
International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17 November.
101- β-Radiation brachytherapy for large choroidal melanoma: Do we need A high dose
to the apex?
Naseripour M, falavarjani KG, Jaberi R, Irani AR, Azma Z.
International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17
November.
102- Multidisciplinary coordinated services: what we need to improve in the management
of RB. Naseripour M, Nazari H, Falavarjani KG, Soudi R, Maleki A, Ansari S.
International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17 November.
103- Central serous chorioretinophaty.
Controversies in ophthalmology 20-22 july 2011.
104- Results of the Comparison of AMD Treatment Trials (CATT Study).
Shahid Beheshti University of Medical Sciences. February 1-3, 2012.
28
105-Moderator of Oncology session in WOC.
Hind Alkatan, Santosh Honavar, Naseripour M, Jacob pe`er, Jerry Shields.
12th MEACO International Congress.16-20 February 2012, Abu Dhabi, United Arab
Emirates.
106- Miscellaneous Tumors / Photodynamic therapy (PDT): is it an effective treatment
modality for retinal and choroidal vascular Tumors?
Naseripour M .12th MEACO International Congress.16-20 February 2012, Abu Dhabi,
United Arab Emirates.
107- Jerry Slields, Naseripour M. Rapid Fire papers: chairpersons.
12th MEACO International Congress.16-20 February 2012, Abu Dhabi, United Arab
Emirates.
108 - Rapid Fire papers: Mystery Case. Naseripour M
12th MEACO International Congress.16-20 February 2012, Abu Dhabi, United Arab
Emirates.
109- Vitreoretinal considerations in cataract surgery. (Vitreoretinal interface changes after
cataract surgery (OCT Findings)). Naseripour M
‫ محمود آباد مازندران‬، 1391 ‫ اردیبهشت‬15 ‫ تا‬12 ،‫ پیوند قرنیه و کاتاراکت‬،‫هجدهمین سمینار سالیانه فارابی‬
110- Ocular pathology & tumors 3. Uveal Nevus. APAO/SOE Busan 2012, 13-16 April
2012. Naseripour M. Bexco, Busan, Korea.
111- Invited lecturer by Visual Sciences groups. Chaharshanbe-Soori Injuries Forum.
Naseripour M.
‫ سمینار فارابی‬1390 ‫ اسفند ماه‬12 ‫ و‬11
29
112- Nine Novel RBI Mutation and Genotype/ Phenotype Correlation in Patients with
Retinoblastoma Referred to Rassoul Akram Hospital. Naseripour M.
‫ سمینار فارابی‬1390 ‫ اسفند ماه‬12 ‫ و‬11
113- Naseripour M. Update in Retinoblastoma
‫رشت‬-‫زیبا کنار‬1391 ‫ خرداد ماه‬12 ‫ و‬11
115- MasoodNaseripourand ArunD.Singh ,Retinoblstoma:Enucleation Chapter in”
Pocket Guild to Ocular Oncology and Pathology”by Hans E.Grossniklaus.Springer
Heidelberg New York Dordrecht London ISBN 978-3-642-28911-8,2012.
116- Naseripour M. How far do you continue the treatment in exudative ARMD?
Controversies in ophthalology .Eye Research Center,Rassoul Akram Hospital,Tehran
Unversity of Medical Sciences. 11-13 jul 2012.
117- Symposium: Retina Disease (Part1), (Results of the comparison of AMD Treatment
Trials (CATT Study)): Naseripour M . Advances and innovations in ophthalmology.
7th Annual Meeting of the Ophthalmic Research Center. Shahid beheshti University
of Medical Sciences. February 1-3, 2012.
118- Vitreoretinal considerations in cataract surgery. (Vitreoretinal interface changes after
cataract surgery (OCT Findings)). Masood Naseripour. ‫ پیوند‬،‫هجدهمین سمینار سالیانه فارابی‬
‫ قرنیه و کاتاراکت‬,‫ محمود آباد مازندران‬. 1391 ‫ اردیبهشت‬15 ‫ تا‬12
119- Naseripour Masood,Live surgery Performed in XXII Annual Congress Of The
Iranian Society Of Ophthalmology ,30 oct2012.
30
120- Naseripour Masood,Free Papers:Posterior Segment, Moderated in XXII Annual
Congress Of The Iranian Society Of Ophthalmology ,31oct2012.
121- Naseripour Masood,Temporary Keratoprosthesis:TPK,K-pro..Video Presented in
posterior Segment Trauma Workshop in XXII Annual Congress Of The Iranian Society Of
Ophthalmology ,1nov2012
122- Naseripour Masood,Genotype – Phenotype Correlation in Iranian Patients with
Retinoblastoma, Oral Presentation in XXII Annual Congress Of The Iranian Society Of
Ophthalmology ,1nov2012.
123- Naseripour Masood,The Trend in the Survival of the Patient with Retinoblastoma,
Poster Presentation in XXII Annual Congress Of The Iranian Society Of Ophthalmology
,1nov2012.
124- Nasseripour Masoud, The Chair of Free Paper, IRAVO Congress, 7march 2013
125- Nasseripour Masoud,Genotype-Phenotype Correlation in Iranian Patients with
Retinoblastoma,Oral Presentation in IRAVO Congress, 8march 2013
126- :‫ ارائه در برنامه فوق تخصصی گروه رتین‬.‫ رویکرد به ضایعات پیگمانته فوندوس‬.‫دکتر مسعود ناصری پور‬
‫ نوزدهمین سینار سالیانه فارابی و ششمین گردهمایی گروه فوق تخصصی ویتر‬.‫رویکرد به بیماریهای ویتره و رتین‬
‫ نوزدهمین سینار سالیانه فارابی‬.1392 ‫ اردیبهشت‬5 ، ‫هتل المپیک‬، ‫تهران‬،‫و رتین انجمن چشم پزشکی ایران‬
127- ‫ اندوفتالمیت پس از‬: ‫ ارائه در سمپوزیوم‬. ‫ اندوفتالمیت پس از جراحی کاتاراکت‬.‫دکتر مسعود ناصری پور‬
‫ نوزدهمین سینار سالیانه فارابی و ششمین گردهمایی گروه فوق تخصصی ویتر و رتین انجمن‬.‫جراحی کاتاراکت‬
‫ نوزدهمین سینار سالیانه فارابی‬.1392 ‫ اردیبهشت‬6 ، ‫هتل المپیک‬، ‫تهران‬،‫چشم پزشکی ایران‬
31
Teaching Experience
Topic 1: Ophthalmology
Topic 2: Medical Education
32